Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02528097 · ClinicalTrials.gov registry record · NA
A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02528097: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT02528097 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02528097, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Spontaneous bacterial peritonitis (SBP) is a common and frequently fatal complication of end-stage liver disease with a mortality of up to 10% primarily due to the development of kidney failure. Current standard practice is to treat this infection with broad spectrum antibiotics and salt-poor albumin administration on day one and three of treatment. In this study the investigators test the hypothesis that the administration of a second dose of albumin at 48 hours only to patients with renal insufficiency is as effective at preventing kidney failure as administering the second dose to all patients at 72 hours. In addition, a kidney function determined approach to albumin dosing may lead to substantial cost and resource saving from decreased albumin use without compromising treatment efficacy.
Primary Outcome
Primary outcome is the presence of renal failure at any point from the start of the study (time 0) through 72 hours
Interventions
- DRUG Standard Care
- DRUG Experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-01 |
| Phase | NA |
Why NCT02528097 stopped before completion
NCT02528097 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02528097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02528097 about?
NCT02528097 is a clinical study titled "A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis". Spontaneous bacterial peritonitis (SBP) is a common and frequently fatal complication of end-stage liver disease with a mortality of up to 10% primarily due to the development of kidney failure. Current standard practice is to treat this infection with broad spectrum antibiotics and salt-poor albumi...
What is the current status of trial NCT02528097?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02528097?
The interventions under investigation include: Standard Care (DRUG), Experimental (DRUG).
Who is sponsoring clinical trial NCT02528097?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02528097's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia